An electrophysiological perspective on Parkinson’s disease: symptomatic pathogenesis and therapeutic approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
An electrophysiological perspective on Parkinson’s disease: symptomatic pathogenesis and therapeutic approaches ; volume:28 ; number:1 ; day:9 ; month:12 ; year:2021 ; pages:1-14 ; date:12.2021
Journal of biomedical science ; 28, Heft 1 (9.12.2021), 1-14, 12.2021
- Urheber
-
Lee, Lan-Hsin Nancy
Huang, Chen-Syuan
Chuang, Hsiang-Hao
Lai, Hsing-Jung
Yang, Cheng-Kai
Yang, Ya-Chin
Kuo, Chung-Chin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-021-00781-z
- URN
-
urn:nbn:de:101:1-2022021117595648474295
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Lan-Hsin Nancy
- Huang, Chen-Syuan
- Chuang, Hsiang-Hao
- Lai, Hsing-Jung
- Yang, Cheng-Kai
- Yang, Ya-Chin
- Kuo, Chung-Chin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Electrophysiological signatures of anxiety in Parkinson’s disease
Correction: Electrophysiological signatures of anxiety in Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
Therapeutic drug monitoring in Parkinson’s disease
Genotype-driven therapeutic developments in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Functional characterization of HtrA2 in the pathogenesis of Parkinson´s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches
Electrophysiological signatures of anxiety in Parkinson’s disease
Correction: Electrophysiological signatures of anxiety in Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
Therapeutic drug monitoring in Parkinson’s disease
Genotype-driven therapeutic developments in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Functional characterization of HtrA2 in the pathogenesis of Parkinson´s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches
Electrophysiological signatures of anxiety in Parkinson’s disease
Correction: Electrophysiological signatures of anxiety in Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
Therapeutic drug monitoring in Parkinson’s disease
Genotype-driven therapeutic developments in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Functional characterization of HtrA2 in the pathogenesis of Parkinson´s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease